PVD Faucet Finishes Market Would Be $11.8 Billion By 2020 | CAGR 7.3%: Grand View Research, Inc.

The PVD Faucet Finishes Market size in U.S., Germany, and China is expected to value USD 11.8 billion by 2020, according to a new report by Grand View Research, Inc., exhibiting a 7.3% CAGR during the forecast period. Increasing expenditure on renovation by hotel groups and rise in home constructions are expected to drive demand for PVD faucet finishes. Increasing urbanization is another factor fueling market growth.

Physical Vapor Deposition (PVD) refers to the process of bonding a finish to a faucet. This process is preferred over powder coating, atomic layer deposition, and electroplating as faucets with PVD finishes offer resistance to scratches, wear and tear, and corrosion, and enhance durability. Several faucet manufacturing companies have been using this process in place of conventional electroplating processes.

North America and Europe are major travel destinations and the growing number of visitors is boosted the hotel and lodging industry in these regions. This, in turn, has fueled expenditure on building new hotels and rooms with advanced technologies and classic as well as unique interior fixtures. As a result, demand for different types of PVD faucet finishes is anticipated to be on the rise over the forecast period.

The global housing market is also expected to contribute significantly to the U.S., China, and Germany market for PVD faucet finishes. Rise in residential construction has led to demand for additional housing faucets, including bathroom and kitchen faucets and related fixtures and this is likely to fuel market growth in the coming years.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/physical-vapor-deposition-pvd-faucet-finishes-market

 Further key findings from the report suggest:

• In 2016, China was estimated to be the largest market, followed by U.S. In China, the highest demand for faucets stemmed from the hotel industry, in terms of both volume and revenue. The industry constituted a share of 69.75% of the total market in terms of volume
• International multi-chain hotels are penetrating into tier-II and tier-III cities in China to capitalize on the growth potential created by expanding middle class population. This section of the society has been seeking premium hospitality services in the country in recent times  
• In U.S., the physical vapor deposition faucet finishes market was dominated by the residential homes segment, which is expected to increase from 9,302,992 faucets in 2016 to 10,598,304 faucets by 2020
• In Germany, physical vapor deposition faucet finishes are witnessing high demand in the home-use segment. The number of newly constructed homes is gradually increasing due to rising government support and easy availability of finances
• In terms of color variation, chrome faucets was the largest segment in 2016 and is expected to register a CAGR of 7.7% from 2017 - 2020
• Key players include Kohler Co.; Hansgrohe SE; GROHE AG; California Faucets, Inc.; Delta Faucet Company; American Faucets & Coatings Corporation; and Moen, Inc.

Grand View Research has segmented physical vapor deposition (PVD) faucet finishes market on the basis of color variation, application, and region.

PVD Faucet Finishes Color Variation Outlook (Volume, Number of Faucets; Revenue, USD Million, 2015 - 2020)

• Chrome
• Nickel
• Rose
• Black
• Gold

PVD Faucet Finishes Application Outlook (Volume, Number of Faucets; Revenue, USD Million, 2015 - 2020)

• Home Use
• Hotel Use

PVD Faucet Finishes Country Outlook (Volume, Number of Faucets; Revenue, USD Million, 2015 - 2020)

• US.
• Germany
• China

Browse Press Release of this Report: www.grandviewresearch.com/press-release/physical-vapor-deposition-pvd-faucet-finishes-market-analysis

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Antifungal Drugs Market Size Is Set To Reach $12.6 Billion By 2025: Grand View Research, Inc.

The global Antifungal Drugs Market was valued at USD 10.7 billion in 2015 and is expected to reach a value of USD 12.6 billion by 2025. The increasing incidence of fungal infections worldwide is the key contributing factor for the growth of the antifungal drugs market in the coming years. Rising adoption of immunosuppressive andantineoplastic agents, prosthetic devices and grafts, and broad-spectrum antibiotics have resulted in the increasing incidence of fungal infections in the recent years.

The growing geriatric population prone to infectious diseases and higher prevalence of chronic conditions, including HIV and cancer, are further contributing toward the rising demand for antifungals to treat opportunistic fungal infections over the forecast period. The large demand for these fungistatic agents is due to the nature of fungal infections, which are difficult to diagnose, yielding high mortality and morbidity rates.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/antifungal-drugs-market

Further Key Findings from the Study Suggest:

• Echinocandins segment is anticipated to exhibit lucrative growth owing to their cell wall-specific fungicidal property coupled with theiUr broad-spectrum activity against Aspergillusand Candida species without cross-resistance risks
• Candidiasis indication segment is anticipated to witness the fastest CAGR over the forecast period due to the increasing drug resistance of the Candida speciesto Azoles
• North America held the largest market share as of 2015, which is attributable to higher awareness levels pertaining to the treatment of fungal infection and presence of target diseases in the population
• Asia pacific is predicted to exhibit the fastest growth due to improving healthcare facilities coupled with rising government initiatives to create awareness of infectious diseases amongst the population
• The companies are focusing on the development of effective therapeutic agents for the treatment of systemic fungal infections in immune-compromised patients
• Numerous ongoing public-private partnership agreements in the pharmaceutical industry for the development of novel therapeutics is predicted to provide this market with lucrative growth opportunities
• For example, the public-private partnership, namely Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator is anticipated to provide USD 44 million in 2016 and around USD 350 million in the coming 5 years to boost the R&D pipeline
• The partners involved in this partnership are the U.S. Department of Health and Human Services, the Antimicrobial Resistance Centrein England, and Boston University School of Law

Grand View Research has segmented the antifungal drugs market by drug class, indication, and region:

Global Antifungal Drugs Class Outlook (Revenue, USD Million, 2014 - 2025)

• Azoles
• Echinocandins
• Polyenes
• Allylamines
• Others

Global Antifungal Drugs Indication Outlook (Revenue, USD Million, 2014 - 2025)

• Dermatophytosis
• Aspergillosis
• Candidiasis
• Others

Antifungal Drugs Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• The Middle East and Africa
  • South Africa

Browse Full Press Release of This Report:  www.grandviewresearch.com/press-release/global-antifungal-drugs-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Beverage Cans Market Total Value Is To Be USD 60.92 Billion By 2024: Grand View Research, Inc.

The global Beverage Cans Market size is expected to reach USD 60.92 billion by 2024, according to a new report by Grand View Research, Inc. owing to increasing demand for compact beverage packaging solutions.

Increasing demand for energy drinks and canned cold coffee and iced tea in Europe and Latin America is expected to drive growth over the forecast period. Increasing consumption of canned beverages in major sports tournaments such as Major League Baseball, Barclays Premier League and La Liga owing to increased convenience in handling the beverage is expected to propel the demand for beverage cans over the forecast period.

Increasing demand for carbonated soft drinks and other flavored soda drinks in North America is expected to positively influence the demand for metal cans over the forecast period. In addition, the growth is expected to be driven by extensive promotional programs undertaken by soft drink manufacturers such as Coca-Cola is expected to have a positive impact on market growth.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/beverage-cans-market 

Further key findings from the report suggest

• Carbonated soft drinks application segment is expected to witness the highest growth of over 5% from 2016 to 2024 owing to growing demand for the aerated drinks in developing economies such as India, Mexico, and Thailand
• High demand for beverage cans in the distribution of fruits & vegetable juices is expected to have a positive impact on growth. Rise in consumption of packaged fruit juices owing to consumers leading a healthier lifestyle is expected to propel demand.
• Europe beverage cans market, was valued at more than USD 9 billion in 2015 which is expected to grow at a CAGR of over 4% from 2016 to 2024 owing to increased recycling activities undertaken by the regulatory bodies including European Commission and national governments of France, Germany, and UK
• Asia Pacific is expected to register a CAGR growth of over 5% from 2016 to 2024 owing to increased demand for carbonated soft drinks, energy drinks and sports drinks owing to increasing disposable income in the developing economies such as China, India, and Indonesia
• The major players in the industry adopt mergers and acquisitions as a key strategy for increasing the market presence. Crown Holdings Inc. acquired EMPAQUE; a leading aluminum can manufacturer in Mexico to expand its market share in the region.

Grand View Research has segmented the global beverage cans market on the basis of product, application and region:

Product Outlook (Volume, Million cans; Revenue, USD Million, 2013 - 2024)

• Aluminum
• Steel

Application Outlook (Volume, Million cans; Revenue, USD Million, 2013 - 2024)

• Carbonated Soft Drinks
• Alcoholic Beverages
• Fruit & Vegetable Juices
• Others

Regional Outlook (Volume, Million cans; Revenue, USD Million, 2013 - 2024)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Russia
  • Spain
• Asia Pacific
  • China
  • India
  • Australia
• Latin America
  • Brazil
• Middle East & Africa
  • South Africa

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-beverage-cans-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Masterbatch Market is Foreseen To Jump Up $15.81 Billion By 2025 | CAGR: 6.6%: Grand View Research, Inc.

The global Masterbatch Market is expected to reach USD 15.81 billion by 2025, according to a new report by Grand View Research, Inc. The market is anticipated to grow at a CAGR of 6.6% primarily driven by increasing replacement of metal by plastic is projected to fuel the market growth. In addition, rising demand from the European region is further expected to propel the demand over the forecast period. 

In terms of revenue, color masterbatch was the largest segment in 2016 and the trend is anticipated to continue at a growth rate of 7.1% over the forecast period. Increasing need for improving the surface appearance of plastic components in automotive, building & construction, and consumer goods is expected to contribute to the growth. Additive masterbatch is being widely used on account of various properties it imparts to plastics such as antistatic, antifoaming, antioxidant, antimicrobial, thermo-stabilizer, barrier properties, metal deactivators, antiblock, flame retardant, UV stabilizer, oxygen scavenger, and abrasion resistance. The growth of packaging sector, especially plastic packaging, is anticipated to drive the masterbatch demand.

Masterbatch is used in various end-use industries, such as packaging, building & construction, consumer goods, automotive, agriculture, as it imparts useful functional properties such as smooth surface finish and desired hardness. The increasing spending capability of customers toward purchasing attractively packaged consumer goods is expected to trigger the need for various plastic components, which use masterbatches to improve the appearance and other properties. These factors together are anticipated to boost masterbatch market demand over the forecast period.

Access Full Research Report on Masterbatch Market: www.grandviewresearch.com/industry-analysis/masterbatch-market

Further key findings from the report suggest:

• Color segment is expected to experience the fastest growth, in terms of value, at a CAGR of 7.1% from 2017 to 2025 as color masterbatch finds application in various end-use industries such as packaging, building & construction, consumer goods, automotive, and agriculture
• Polyethylene emerged as the largest carrier polymer segment, in terms of revenue, in 2016 and is estimated to be valued at USD 5,461.8 million by 2025. The growing popularity on account of useful properties of HDPE, LDPE, and LLDPE is projected to drive the growth.
• Packaging was estimated as the largest end-use industry due to different types of industrial, customer, and retail packaging segments across various geographies
• The U.S. masterbatch market, in terms of revenue, was valued at USD 1,624.3 million in 2016 and is estimated to reach USD 2,920.3 million by 2025. The consumer goods industry in the U.S. is projected to witness the fastest growth over the next eight years owing to the increasing demand from customers.
• Key players including A. Schulman, Inc., Ampacet Corporation, Cabot Corporation, Clariant AG, Plastiblends India Ltd., and Global Colors Group have a prominent presence in the global masterbatch market

Grand View Research has segmented the global masterbatch market on the basis of type, carrier polymer, end use, and region.

Masterbatch, Type Outlook (Volume, Kilo Tons; Revenue, USD Million; 2014 - 2025)

• White
• Black
• Color
• Additive
• Filler

Masterbatch Carrier Polymer Outlook (Volume, Kilo Tons; Revenue, USD Million; 2014 - 2025)

• Polypropylene (PP)
• Polyethylene (PE)
• Polyvinyl Chloride (PVC)
• Polyethylene Terephthalate (PET)
• Others

Masterbatch Market End Use Outlook (Volume, Kilo Tons; Revenue, USD Million; 2014 - 2025)

• Packaging
• Building & Construction
• Consumer Goods
• Automotive
• Agriculture
• Others

Masterbatch Regional Outlook (Volume, Kilo Tons; Revenue, USD Million; 2014 - 2025)

• North America
  • US.
• Europe
  • Germany
  • UK
  • France
• Asia Pacific
  • China
  • India
  • Japan
• Central & South America
  • Brazil
• Middle East & Africa

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-masterbatch-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Rheumatoid Arthritis Drugs Market Is Poised To Reach $30.4 Billion By 2025: Grand View Research, Inc.

The global Rheumatoid Arthritis Therapeutics Market size is expected to reach USD 30.4 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 4.6% during the forecast period. Some of the key trends driving the market are availability of novel biologics, increase in potential clinical pipeline candidates, and rise in aging population. Thus, growing availability and awareness of safer drugs are projected to escalate rheumatoid arthritis drugs market growth. 

Rheumatoid arthritis affects approximately 1% of the global population. The condition has different symptoms such as joint pain, swelling, and stiffness, which are generally accompanied by chronic pain and inability to perform daily activities. Over a prolonged period, this disorder can hamper a patient’s mobility and can lead to permanent joint damage. If left untreated, this disorder can lead to mobility impairment and risk of joint replacement.

Growing prevalence of the disease, presence of biologics & biosimilars, and well-defined regulatory guidelines are poised to provide a fillip to the market. According to the Arthritis Foundation, 64% of the population within the age group of 65 is likely to suffer from arthritis in U.S. Increasing awareness regarding disease remittance therapies and rising healthcare expenditure in developed regions are estimated to promote revenue growth.

Current treatment for rheumatoid arthritis includes generic pharmaceuticals such as NSAIDs and corticosteroids along with novel biologics such as JAK inhibitors and IL-6 antagonists, which are widely used in developed countries due to their high effectiveness. New product launches such as Infliximab and Adalimumab biosimilars are anticipated to work in favor of the market. Moreover, Eli Lilly’s Olumiant and AbbVie’s Upadacitinib are expected to cut down chances of disease remittance.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/rheumatoid-arthritis-therapeutics-market

Further key findings from the report suggest:

• North America held 56.6% of the market in 2016 due to rising awareness regarding disease treatment, growing geriatric population, and high adoption of biopharmaceuticals for treatment
• Due to growing popularity, the biopharmaceuticals segment is projected to exhibit a CAGR of 8.3% during the forecast period
• Prescriptions are anticipated to emerge as more reliable and a preferred sales channel over the same period
• Asia Pacific is the most promising region, registering a CAGR of 9.5% between 2017 and 2025
• Some of the key players in rheumatoid arthritis market are AbbVie; Boehringer Ingelheim GmbH; Novartis AG; Regeneron Pharmaceuticals, Inc.; Pfizer, Inc.; Bristol-Myers Squibb Company; F. Hoffmann-La Roche Ltd.; UCB S.A.; Johnson & Johnson Services, Inc.; and Amgen, Inc.

Grand View Research has segmented the rheumatoid arthritis drugs/therapeutics market on the basis of molecule types, sales channels, and region:

Rheumatoid Arthritis Therapeutics Molecule Outlook (Revenue, USD Million, 2014 - 2025)

• Pharmaceuticals
  • NSAIDs
  • Analgesics
  • DMARDs
  • Glucocorticoids
• Biopharmaceuticals
  • Biologics
    • TNF-α antagonists
    • T-cell inhibitors
    • CD20 antigen
    • JAK inhibitors
    • anti-IL6 biologics
  • Biosimilars
    • CD20 antigen
    • TNF-α antagonists

Rheumatoid Arthritis Therapeutics Sales Channel Outlook (Revenue, USD Million, 2014 - 2025)

• Prescription
• Over-the-Counter (OTC)

Rheumatoid Arthritis Therapeutics Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-rheumatoid-arthritis-therapeutics-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Deep Brain Stimulators Market Is Set To Beat $1.6 Billion By 2020: Grand View Research, Inc.

The Global Deep Brain Stimulators Market is expected to reach USD 1,592.9 million by 2020, according to a new study by Grand View Research, Inc. Increasing prevalence of Parkinson’s disease coupled with rising demand for cost effective & minimally invasive surgical procedures are the factors attributing towards the growth of deep brain stimulators market.  According to statistics published by Parkinson Disease Foundation, approximately 10 million people were suffering from this disease in 2010 and the number was anticipated to grow manifolds over the forecast period thereby contributing to the overall industry growth.

The significant increase in the adoption of DBS by neurologist for the treatment of Parkinson’s disease, essential tremors, obsessive compulsive disorder and Dystonia is expected to drive the market growth in coming years. Pending commercialization approval from the U.S. FDA for use of DBS in treatment of refractory epilepsy is also expected to boost the market growth in near future. Furthermore, introduction of technologically advanced selective current steering and fractionation of electric current is further expected to enhance the usage of deep brain stimulators in the near future.

Access Full Research Report on Deep Brain Stimulators Market: www.grandviewresearch.com/industry-analysis/deep-brain-stimulators-dbs-market

Further key findings from the study suggest:

• DBS found wide application in Parkinson’s disease treatment and is expected to grow at CAGR of above 18.0% due to associated benefits such as fewer side effects, improvised motor symptoms for longer time period and tracking of momentary fluctuations.  In addition, shifting of preference from conventional oral medications to DBS, due to drug resistant nature of Parkinson’s disease is further expected to increase adoption of DBS over the forecast period.
• Obsessive compulsive disorder followed Parkinson’s disease in terms of revenue share due to failure of conventional serotonin reuptake inhibitors (SSRi) treatment and offered benefits such as adjustable & reversible stimulations, and nondestructive nature of treatment.  
• North America held the dominant share, accounting for over 50.0% in 2013. Presence of sophisticated healthcare infrastructure, increasing awareness levels of patients and healthcare personnel and supportive reimbursement policies are some of the key reasons driving growth of deep brain stimulators regional industry.
• Asia Pacific region is expected to be fastest growing market for DBS and grow at CAGR of over 18.0% during the forecast period. Constantly improving healthcare facility, presence of high unmet needs and rising expenditure levels are accounted for its significant growth.
• Key players of deep brain stimulators industry include Aleva Neurotherapeutics SA, Boston Scientific Corporation, St. Jude Medical, and Medtronic Plc. Increasing clinical applications of DBS systems and extensive R&D pertaining to development of advanced technology are the factors propelling industrial growth. Players are adopting competitive strategy such as new product development for sustaining the competition.

Grand View Research has segmented the global deep brain stimulators market on the basis of application and region:

Global Deep Brain Stimulators Application Outlook (Revenue, USD Million, 2012 - 2020)

• Pain Management
• Epilepsy
• Essential Tremor
• Obsessive Compulsive Disorder (OCD)
• Depression
• Dystonia
• Parkinson’s Disease
• Others

Deep Brain Stimulators Regional Outlook (Revenue, USD Billion, 2012 - 2020)

• North America
  • US.
• Europe
  • Germany
  • UK
• Asia Pacific
  • Japan
• RoW
  • Brazil

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-deep-brain-stimulators-dbs-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Industrial Automation And Huge Investment Is Likely To Accelerate The AGV Market Toward Rapid Growth Till 2024

The automated guided vehicle (AGV) market is expected to reach USD 1.5 billion by 2024, according to a new study conducted by Grand View Research, Inc. The growing focus on industrial automation, worldwide, is expected to contribute to the revenue growth.

The manifold advantages offered by AGVs, such as reduction in the operational cost, decrement in the production time, and enhanced workforce safety, are substantially energizing the industry growth prospects. These vehicles offer dynamic design solutions that pertinently replace the conventional conveyor systems and their associated high costs. Innovative technologies, such as laser, vision, and natural guidance, are instrumental in creating a high potential for the automated guided vehicle market growth. AGVs with such advanced wireless navigation technologies help in eliminating the need for expensive retrofitting, which is one of the primary factors behind their adoption.

This escalating demand for material handling equipment is projected to drive the market growth over the forecast period. Firms, operating in the warehouse businesses, are focusing on increasing spending on these vehicles to meet the growing demand for their services and to improve the efficiency of their operations.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/automated-guided-vehicle-agv-market

Further key findings from the study suggest:

• The tow vehicles segment was valued at USD 297.3 million in 2015 and is expected to grow at a CAGR of 7.6% over the forecast period. Such vehicles have considerable demand due to their ability to move more loads with multiple trailers than a single fork truck. This segment is expected to be driven by its advantages such as planned computerized operations and increased employee safety.
• The AGV market is technology-driven and the OEMs are focusing on enhancing the capabilities of their existing products. The natural navigation technology segment is anticipated to show a high potential, owing to its benefits, such as reduced infrastructure costs, as the natural navigation eliminates the need of reflectors and markers. The natural navigation technology segment was valued at over USD 18.4 million in 2015 and is expected to be the key navigation technology segment in the near future.
• Based on application, the market is segmented into logistics, assembly and packaging. The assembly and packaging application segment is estimated to be a key segment over the next 8 years and is estimated to grow at a CAGR of 6.6% from 2016 to 2024.
• The retail end-use industry is undergoing a rapid growth phase and is presumed to offer remarkable growth opportunities for the AGV market growth. The retail end-use industry is expected to reach USD 353.6 million by 2024.
• The Asia Pacific region is estimated to be the key region and the market for AGV in this region was valued at over USD 320.6 million in 2015, and is expected to expand at a CAGR of 7.6% from 2016 to 2024. The regional growth is supported by the increasing manufacturing and logistics activities in the emerging countries such as China and India. For instance, Amazon.com, Inc. has deployed several Kiva AGVs, at its Chinese warehouse, to effectively manage its logistics activities.
• The key vendors dominating the industry include Swisslog Holding AG, Egemin Automation, Inc., Bastian Solutions, Inc., Daifuku Co., Ltd., Dematic Corp., JBT Corporation, Seegrid Corporation, Toyota Industries Corporation, Hyster-Yale Group, Inc., Baylo, Inc., EK Automation, Kollmorgen, and KMH Systems, Inc.

Grand View Research has segmented the AGVs market based on type, navigation technology, application, end-use industry, and region:

AGVs Type Outlook (Revenue, USD Million, 2014 - 2024)

• Tow vehicle
• Unit load career
• Pallet truck
• Forklift truck
• Others

AGVs Navigation Technology Outlook (Revenue, USD Million, 2014 - 2024)

• Laser guidance
• Magnetic guidance
• Natural navigation
• Vision guided

AGVs Application Outlook (Revenue, USD Million, 2014 - 2024)

• Logistics
• Assembly and packaging

AGVs End-use Industry Outlook (Revenue, USD Million, 2014 - 2024)

• Automotive
• Food and beverage
• Aerospace
• Healthcare
• Retail

AGVs Region Outlook (Revenue, USD Million, 2014 - 2024)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
• The Middle East and Africa

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-automated-guided-vehicle-agv-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com